Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Multicenter, Randomized, Active-Controlled, Double-Blind, Double-Dummy, Parallel Group Clinical Trial, Investigating the Efficacy, Safety and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison...(260930)


Collapse Overview 
Collapse sponsor award id
ND0612-317


Collapse Biography 

Collapse Time 
Collapse start date
2021-03-03

Collapse end date
2031-03-24